Alcohol Approach Bias Is Associated With Both Behavioral and Neural Pavlovian-to-Instrumental Transfer Effects in Alcohol-Dependent Patients.

Alcohol approach bias Alcohol use disorder Pavlovian-to-instrumental transfer Relapse Trait impulsivity fMRI

Journal

Biological psychiatry global open science
ISSN: 2667-1743
Titre abrégé: Biol Psychiatry Glob Open Sci
Pays: United States
ID NLM: 9918227369306676

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 13 01 2022
revised: 04 03 2022
accepted: 30 03 2022
medline: 14 4 2022
pubmed: 14 4 2022
entrez: 31 7 2023
Statut: epublish

Résumé

Even after qualified detoxification, alcohol-dependent (AD) patients may relapse to drinking alcohol despite their decision to abstain. Two mechanisms may play important roles. First, the impact of environmental cues on instrumental behavior (i.e., Pavlovian-to-instrumental transfer [PIT] effect), which was found to be stronger in prospectively relapsing AD patients than in abstaining patients. Second, an automatic approach bias toward alcohol stimuli was observed in AD patients, and interventions targeting this bias reduced the relapse risk in some studies. Previous findings suggest a potential behavioral and neurobiological overlap between these two mechanisms. In this study, we examined the association between alcohol approach bias and both behavioral and neural non-drug-related PIT effects in AD patients after detoxification. A total of 100 AD patients (17 females) performed a PIT task and an alcohol approach/avoidance task. Patients were followed for 6 months. A stronger alcohol approach bias was associated with both a more pronounced behavioral PIT effect and stronger PIT-related neural activity in the right nucleus accumbens. Moreover, the association between alcohol approach bias and behavioral PIT increased with the severity of alcohol dependence and trait impulsivity and was stronger in patients who relapsed during follow-up in the exploratory analysis. These findings indicate partial behavioral and neurobiological overlap between alcohol approach bias and the PIT effect assessed with our tasks. The association was stronger in patients with more severe alcohol dependence.

Sections du résumé

Background UNASSIGNED
Even after qualified detoxification, alcohol-dependent (AD) patients may relapse to drinking alcohol despite their decision to abstain. Two mechanisms may play important roles. First, the impact of environmental cues on instrumental behavior (i.e., Pavlovian-to-instrumental transfer [PIT] effect), which was found to be stronger in prospectively relapsing AD patients than in abstaining patients. Second, an automatic approach bias toward alcohol stimuli was observed in AD patients, and interventions targeting this bias reduced the relapse risk in some studies. Previous findings suggest a potential behavioral and neurobiological overlap between these two mechanisms.
Methods UNASSIGNED
In this study, we examined the association between alcohol approach bias and both behavioral and neural non-drug-related PIT effects in AD patients after detoxification. A total of 100 AD patients (17 females) performed a PIT task and an alcohol approach/avoidance task. Patients were followed for 6 months.
Results UNASSIGNED
A stronger alcohol approach bias was associated with both a more pronounced behavioral PIT effect and stronger PIT-related neural activity in the right nucleus accumbens. Moreover, the association between alcohol approach bias and behavioral PIT increased with the severity of alcohol dependence and trait impulsivity and was stronger in patients who relapsed during follow-up in the exploratory analysis.
Conclusions UNASSIGNED
These findings indicate partial behavioral and neurobiological overlap between alcohol approach bias and the PIT effect assessed with our tasks. The association was stronger in patients with more severe alcohol dependence.

Identifiants

pubmed: 37519476
doi: 10.1016/j.bpsgos.2022.03.014
pii: S2667-1743(22)00053-2
pmc: PMC10382691
doi:

Types de publication

Journal Article

Langues

eng

Pagination

443-450

Informations de copyright

© 2022 The Authors.

Références

J Clin Med. 2019 Aug 08;8(8):
pubmed: 31398853
Genes Brain Behav. 2009 Feb;8(1):101-6
pubmed: 19016889
Neuroimage. 2017 May 1;151:33-44
pubmed: 27480622
Physiol Rev. 2019 Oct 1;99(4):2115-2140
pubmed: 31507244
J Cogn Neurosci. 2013 Sep;25(9):1428-41
pubmed: 23691985
Front Psychol. 2019 Feb 21;10:309
pubmed: 30846951
J Affect Disord. 2019 Feb 15;245:297-304
pubmed: 30439675
Psychother Psychosom Med Psychol. 2007 Jan;57(1):32-8
pubmed: 17357031
Front Psychiatry. 2013 May 22;4:33
pubmed: 23734131
Addict Biol. 2016 May;21(3):719-31
pubmed: 25828702
Front Neuroinform. 2011 Aug 22;5:13
pubmed: 21897815
Eur J Neurosci. 2013 Dec;38(12):3740-8
pubmed: 24118624
PLoS One. 2013 Apr 30;8(4):e61355
pubmed: 23646106
Eur J Neurosci. 2011 Jun;33(12):2274-87
pubmed: 21507084
Addict Biol. 2014 Nov;19(6):965-71
pubmed: 23639056
Alcohol Clin Exp Res. 2016 Sep;40(9):1945-52
pubmed: 27421061
Drug Alcohol Depend. 2013 Jan 1;127(1-3):81-6
pubmed: 22776440
Addiction. 2010 Feb;105(2):279-87
pubmed: 20078486
Psychol Addict Behav. 2014 Mar;28(1):85-96
pubmed: 23438245
Nat Neurosci. 2018 Aug;21(8):1072-1083
pubmed: 30038277
Alcohol. 2021 Nov;96:83-92
pubmed: 34363928
Behav Processes. 2017 Aug;141(Pt 1):26-32
pubmed: 28473252
Psychol Addict Behav. 2015 Mar;29(1):225-30
pubmed: 25134039
J Behav Ther Exp Psychiatry. 2017 Dec;57:215
pubmed: 26987424
Psychopharmacology (Berl). 2015 Mar;232(5):861-70
pubmed: 25163422
J Behav Ther Exp Psychiatry. 2008 Sep;39(3):209-18
pubmed: 17640615
Nephrology (Carlton). 2020 Jul;25(7):513-517
pubmed: 32147926
Behav Cogn Psychother. 2017 Jan;45(1):58-72
pubmed: 27692021
J Neurosci. 2008 Jan 9;28(2):360-8
pubmed: 18184778
Psychol Sci. 2011 Apr;22(4):490-7
pubmed: 21389338
J Physiol Paris. 2015 Feb-Jun;109(1-3):78-86
pubmed: 24954026
Am J Psychiatry. 2015 Apr;172(4):335-43
pubmed: 25526597
Psychol Addict Behav. 2017 Mar;31(2):171-179
pubmed: 27935726
Alcohol Clin Exp Res. 2012 Feb;36(2):361-8
pubmed: 21895719
Am J Psychiatry. 2004 Oct;161(10):1783-9
pubmed: 15465974
Alcohol Clin Exp Res. 2010 Dec;34(12):2022-34
pubmed: 20659066
Br J Pharmacol. 2014 Oct;171(20):4636-72
pubmed: 24749941
Nature. 2011 Jan 6;469(7328):53-7
pubmed: 21150898
Int J Methods Psychiatr Res. 2013 Jun;22(2):83-99
pubmed: 23788523
Neuropsychopharmacology. 2014 Feb;39(3):688-97
pubmed: 24060832
J Neurosci. 2008 May 28;28(22):5861-6
pubmed: 18509047
Dev Cogn Neurosci. 2013 Apr;4:38-51
pubmed: 23218805
J Neural Transm (Vienna). 2016 Aug;123(8):809-21
pubmed: 27145766
Addict Biol. 2020 Jan;25(1):e12703
pubmed: 30561790
Psychol Addict Behav. 2022 Aug;36(5):547-554
pubmed: 34110839
Alcohol Clin Exp Res. 2007 May;31(5):766-74
pubmed: 17378919
Transl Psychiatry. 2017 Aug 1;7(8):e1183
pubmed: 28763064
J Consult Clin Psychol. 2018 Dec;86(12):1005-1016
pubmed: 30507226
Neuropsychopharmacology. 2014 Sep;39(10):2441-9
pubmed: 24804846

Auteurs

Ke Chen (K)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Maria Garbusow (M)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Miriam Sebold (M)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Department for Social and Preventive Medicine, University of Potsdam, Potsdam, Germany.

Sören Kuitunen-Paul (S)

Department of Child and Adolescent Psychiatry, Technische Universität Dresden, Dresden, Germany.
Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.

Michael N Smolka (MN)

Department of Psychiatry, Technische Universität Dresden, Dresden, Germany.

Quentin J M Huys (QJM)

Division of Psychiatry, University College London, London, United Kingdom.
Max Planck UCL Centre for Computational Psychiatry and Ageing Research, University College London, London, United Kingdom.

Ulrich S Zimmermann (US)

University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Department of Addiction Medicine and Psychotherapy, kbo Isar-Amper-Klinikum Region, München, Germany.

Florian Schlagenhauf (F)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Classifications MeSH